Cargando…

Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia

Idarubicin (IDR), cytarabine (AraC), and tamibarotene (Am80) are effective for treatment of acute myeloid leukemia (AML). In acute leukemia, the incidence of venous thromboembolism or disseminated intravascular coagulation is associated with induction chemotherapy. Procoagulant effects of IDR, AraC,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsunaka, Misae, Shinki, Haruka, Koyama, Takatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391104/ https://www.ncbi.nlm.nih.gov/pubmed/28406995 http://dx.doi.org/10.1371/journal.pone.0175765

Ejemplares similares

Cell-based laboratory evaluation of coagulation activation by antineoplastic drugs for the treatment of lymphoid tumors
por: Tsunaka, Misae, et al.
Publicado: (2016)

A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
por: Ocadlikova, Darina, et al.
Publicado: (2020)

Antineoplastic effects of CPPTL via the ROS/JNK pathway in acute myeloid leukemia
por: Gao, Hui-Er, et al.
Publicado: (2017)

PB1832: INFLAMMATION INDUCED COAGULATION IN ACUTE MYELOID LEUKEMIA
por: Ajtić, Olivera Mitrović, et al.
Publicado: (2023)

PB1826: CELLULAR AND MOLECULAR CHARACTERIZATION OF THE ANTINEOPLASTIC EFFECTS OF CEPHALOCHROMIN IN MODELS OF ACUTE MYELOID LEUKEMIA
por: Nascimento, Mariane Cristina Do, et al.
Publicado: (2023)

Electrolyte Disorders Induced by Antineoplastic Drugs
por: Verzicco, Ignazio, et al.
Publicado: (2020)

Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990)

Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation
por: Lee, Hee-Jeong, et al.
Publicado: (2013)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
por: Andresen, Vibeke, et al.
Publicado: (2017)

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
por: Piccolomo, Antonio, et al.
Publicado: (2020)

Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells
por: Ji, Qing, et al.
Publicado: (2016)

Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma
por: Isozumi, Yu, et al.
Publicado: (2013)

Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia
por: Ookura, Miyuki, et al.
Publicado: (2018)

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview
por: Roger, Inés, et al.
Publicado: (2023)

Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979)

Evaluation of apoptosis induced by exposure to antineoplastic drugs in peripheral blood lymphocytes of nurses
por: Liao, Heng, et al.
Publicado: (2017)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

High incidence of disseminated intravascular coagulation and acute cerebral infarction in acute myeloid leukemia with cup-like nuclei
por: Watanabe, Naoki, et al.
Publicado: (2022)

Mechanisms of drug resistance in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2019)

Recent drug approvals for acute myeloid leukemia
por: Lai, Catherine, et al.
Publicado: (2019)

Acute Myeloid Leukemia: An Ever-Changing Disease
por: Nix, Nancy M., et al.
Publicado: (2019)

Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia)
por: Lin, Min, et al.
Publicado: (2018)

The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs
por: Cui, Hui, et al.
Publicado: (2020)

Cell death regulation in myocardial toxicity induced by antineoplastic drugs
por: Yu, Xue, et al.
Publicado: (2023)

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
por: Noura, Mina, et al.
Publicado: (2020)

Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia
por: Xiao, Mengyu, et al.
Publicado: (2022)

Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?
por: Jaramillo, Sonia, et al.
Publicado: (2021)

Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies
por: Quartucci, Caroline, et al.
Publicado: (2023)

Clinical value of new drugs in acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2019)

Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020)

Tumor targeting using liposomal antineoplastic drugs
por: Huwyler, Jörg, et al.
Publicado: (2008)

Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
por: Ralph, Stephen John
Publicado: (2008)

Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells
por: Eschenburg, Georg, et al.
Publicado: (2014)

P1667: ALTERED COAGULATION SCREENING TESTS AT DIAGNOSIS ARE A COMMON FINDING IN ACUTE LEUKEMIAS OF BOTH LYMPHOID AND MYELOID LINEAGES, AND NOT JUST IN ACUTE PROMYELOCYTIC LEUKEMIA
por: Pereira, M., et al.
Publicado: (2022)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Treatment of Relapsed Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2020)

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
por: Layton, Jodi L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tbqfbik6q42q756velaamjh6dh